307 related articles for article (PubMed ID: 12912818)
1. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
Stühlinger MC; Oka RK; Graf EE; Schmölzer I; Upson BM; Kapoor O; Szuba A; Malinow MR; Wascher TC; Pachinger O; Cooke JP
Circulation; 2003 Aug; 108(8):933-8. PubMed ID: 12912818
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
3. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
Böger RH; Lentz SR; Bode-Böger SM; Knapp HR; Haynes WG
Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
5. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
7. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
[TBL] [Abstract][Full Text] [Related]
8. Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease.
Ziegler S; Mittermayer F; Plank C; Minar E; Wolzt M; Schernthaner GH
J Clin Endocrinol Metab; 2005 Apr; 90(4):2175-8. PubMed ID: 15634723
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid.
Usui M; Matsuoka H; Miyazaki H; Ueda S; Okuda S; Imaizumi T
Clin Sci (Lond); 1999 Mar; 96(3):235-9. PubMed ID: 10029559
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.
Tawakol A; Omland T; Gerhard M; Wu JT; Creager MA
Circulation; 1997 Mar; 95(5):1119-21. PubMed ID: 9054838
[TBL] [Abstract][Full Text] [Related]
12. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans.
Kanani PM; Sinkey CA; Browning RL; Allaman M; Knapp HR; Haynes WG
Circulation; 1999 Sep; 100(11):1161-8. PubMed ID: 10484535
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Yoo JH; Lee SC
Atherosclerosis; 2001 Oct; 158(2):425-30. PubMed ID: 11583722
[TBL] [Abstract][Full Text] [Related]
14. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading.
Wanby P; Brattström L; Brudin L; Hultberg B; Teerlink T
Scand J Clin Lab Invest; 2003; 63(5):347-53. PubMed ID: 14599157
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
Woo KS; Chook P; Lolin YI; Cheung AS; Chan LT; Sun YY; Sanderson JE; Metreweli C; Celermajer DS
Circulation; 1997 Oct; 96(8):2542-4. PubMed ID: 9355891
[TBL] [Abstract][Full Text] [Related]
17. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
[TBL] [Abstract][Full Text] [Related]
19. Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
Magné J; Huneau JF; Borderie D; Mathé V; Bos C; Mariotti F
Amino Acids; 2015 Sep; 47(9):1975-82. PubMed ID: 25792109
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults.
Bellamy MF; McDowell IF; Ramsey MW; Brownlee M; Bones C; Newcombe RG; Lewis MJ
Circulation; 1998 Nov; 98(18):1848-52. PubMed ID: 9799203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
